Federation des caisses Desjardins du Quebec’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.6K Buy
4,751
+1,320
+38% +$12.4K ﹤0.01% 1582
2025
Q1
$24.4K Buy
3,431
+1,500
+78% +$10.7K ﹤0.01% 1665
2024
Q4
$22.5K Buy
1,931
+1,750
+967% +$20.4K ﹤0.01% 1643
2024
Q3
$3.72K Hold
181
﹤0.01% 2143
2024
Q2
$4.05K Hold
181
﹤0.01% 2003
2024
Q1
$4.98K Hold
181
﹤0.01% 1959
2023
Q4
$5.52K Sell
181
-1,845
-91% -$56.3K ﹤0.01% 1888
2023
Q3
$64.1K Hold
2,026
﹤0.01% 1252
2023
Q2
$82.6K Hold
2,026
﹤0.01% 1207
2023
Q1
$75.5K Buy
2,026
+6
+0.3% +$224 ﹤0.01% 1211
2022
Q4
$70.5K Buy
2,020
+1,230
+156% +$42.9K ﹤0.01% 1361
2022
Q3
$44.2K Buy
+790
New +$44.2K ﹤0.01% 1535
2018
Q3
Sell
-600
Closed -$16.4K 2173
2018
Q2
$16.4K Hold
600
﹤0.01% 1617
2018
Q1
$12.7K Sell
600
-50
-8% -$1.06K ﹤0.01% 1649
2017
Q4
$12.5K Buy
+650
New +$12.5K ﹤0.01% 1666